WLKP Company Profile and Key Details

WLKP has shown weak momentum, losing -3.34% over the past week and -9.48% over the past quarter, though year-to-date performance is down -17.46%. Short-term trend indicators are mixed aligned (SMA20 -0.03%, SMA50 -0.01%, SMA200 -11.26%). The stock’s 14-day RSI is 49.63 (neutral), while the ATR of 0.42 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -23.72% below its high and over 7.61% above its low. Average 10-day trading volume of 62.71 thousand shares is below the 3-month average of 75.09 thousand, indicating normal recent market interest.

Westlake Chemical Partners LP generated EPS of $1.39 over the past year. Five-year average earnings growth is 0.03%. Wall Street analysts project EPS growth of 1.97% annually over the next five years. The latest quarter delivered EPS of $nan. The next quarter is forecast at $0.40. Next year's EPS is expected at $17.41. The prior quarter beat by -7.72%. Over the last six quarters, Apple has recorded several small beats. These include -8.89% in August 06, 2024.

The stock is currently mid-range between its 52-week high and low $17.75 and $25.04. With a market capitalization of about $673.08 million, Westlake Chemical Partners LP is classified as a small-cap and shows lower-than-market volatility (beta ~0.59). Key stats such as the average daily volume over the past year has been around 76.27 thousand shares, in line with its 52-week average. Headquartered in Houston, TX, Westlake Chemical Partners LP operates in the Basic Materials sector and the Chemicals industry. Led by CEO Jean-Marc Gilson, the company employs approximately 2,169 people and listed since July 30, 2014. Westlake Chemical Partners LP acquires, develops, and operates ethylene production facilities and related assets in the United States.

Westlake Chemical Partners LP has 35.24 million shares outstanding. The public float is 19.25 million shares, elevated short interest at 0.40% of float. This equals 82.44 thousand shares. The short ratio is 2.43 days. Institutional investors hold 53.1% of the float. Insiders own 44.84%. TTWFGP LLC holds 1.40 million shares, Kenner Andrew has 185.00 thousand shares and Chao Albert has 164.86 thousand shares. Over the past six months, insider transactions show net buying. They sold 0.00 shares across 0 transactions.

Westlake Chemical Partners LP last paid a dividend of 1.89 per share, this equals a trailing yield of roughly 8.06%. Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $22.91. This means the shares are trading below this model’s fair value.

Our AI price prediction model suggests that Westlake Chemical Partners LP stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 2.72%, with price expected at $19.62 by January 02, 2026, within a range of $19.28 to $19.92 3-Month Outlook: Projected rise of 0.05%, reaching $19.11 by March 19, 2026, with a range of $18.40 to $19.76. 1-Year Outlook: Projected loss of -1.68%, with price at $18.78 by December 18, 2026, within a range of $18.38 to $19.21.

Westlake Chemical Partners LP (NYSE:WLKP) shares are down -17.46% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Westlake Chemical Partners LP trading at a premium to the broader market with a P/E of 5.61. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $26.75, suggesting 40.05% upside. Our AI forecast model points to short-term strength (2.72% over two weeks), a medium-term rise (0.05% over three months), and a longer-term loss (-1.68% over one year), with expected trading ranges indicating moderate volatility.

Westlake Chemical Partners LP trades at a P/E ratio of 5.61, slightly below the S&P 500 average, with a price-to-sales ratio of 0.6 and a price-to-book ratio of 1.35 suggesting the stock is closer to book value. The P/FCF stands at 3.24, also above market averages.